296 related articles for article (PubMed ID: 34729701)
21. The mechanism of binding with the α-glucosidase in vitro and the evaluation on hypoglycemic effect in vivo: Cocrystals involving synergism of gallic acid and conformer.
Xue N; He B; Jia Y; Yang C; Wang J; Li M
Eur J Pharm Biopharm; 2020 Nov; 156():64-74. PubMed ID: 32890659
[TBL] [Abstract][Full Text] [Related]
22. Mechanistic Basis of Cocrystal Dissolution Advantage.
Cao F; Amidon GL; Rodríguez-Hornedo N; Amidon GE
J Pharm Sci; 2018 Jan; 107(1):380-389. PubMed ID: 28989017
[TBL] [Abstract][Full Text] [Related]
23. Cocrystal solubility product analysis - Dual concentration-pH mass action model not dependent on explicit solubility equations.
Avdeef A
Eur J Pharm Sci; 2017 Dec; 110():2-18. PubMed ID: 28392495
[TBL] [Abstract][Full Text] [Related]
24. Critical Analysis and Optimization of Stoichiometric Ratio of Drug-Coformer on Cocrystal Design: Molecular Docking, In Vitro and In Vivo Assessment.
Dhibar M; Chakraborty S; Basak S; Pattanayak P; Chatterjee T; Ghosh B; Raafat M; Abourehab MAS
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259428
[TBL] [Abstract][Full Text] [Related]
25. Exploring Novel Cocrystalline Forms of Oxyresveratrol to Enhance Aqueous Solubility and Permeability across a Cell Monolayer.
Suzuki Y; Muangnoi C; Thaweesest W; Teerawonganan P; Ratnatilaka Na Bhuket P; Titapiwatanakun V; Yoshimura-Fujii M; Sritularak B; Likhitwitayawuid K; Rojsitthisak P; Fukami T
Biol Pharm Bull; 2019; 42(6):1004-1012. PubMed ID: 31155574
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in improving oral drug bioavailability by cocrystals.
Emami S; Siahi-Shadbad M; Adibkia K; Barzegar-Jalali M
Bioimpacts; 2018; 8(4):305-320. PubMed ID: 30397585
[No Abstract] [Full Text] [Related]
27. Effects of coformers on phase transformation and release profiles of carbamazepine cocrystals in hydroxypropyl methylcellulose based matrix tablets.
Qiu S; Li M
Int J Pharm; 2015 Feb; 479(1):118-28. PubMed ID: 25542989
[TBL] [Abstract][Full Text] [Related]
28. pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.
Alhalaweh A; Roy L; Rodríguez-Hornedo N; Velaga SP
Mol Pharm; 2012 Sep; 9(9):2605-12. PubMed ID: 22867056
[TBL] [Abstract][Full Text] [Related]
29. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
[TBL] [Abstract][Full Text] [Related]
30. In vitro, ex vivo, and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil.
Annaert P; Tukker JJ; van Gelder J; Naesens L; de Clercq E; van Den Mooter G; Kinget R; Augustijns P
J Pharm Sci; 2000 Aug; 89(8):1054-62. PubMed ID: 10906729
[TBL] [Abstract][Full Text] [Related]
31. Glibenclamide-malonic acid cocrystal with an enhanced solubility and bioavailability.
Srivastava D; Fatima Z; Kaur CD; Mishra A; Nashik SS; Rizvi DA; Prasad R
Drug Dev Ind Pharm; 2022 Aug; 48(8):417-424. PubMed ID: 36073946
[TBL] [Abstract][Full Text] [Related]
32. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion.
Boksa K; Otte A; Pinal R
J Pharm Sci; 2014 Sep; 103(9):2904-2910. PubMed ID: 24807421
[TBL] [Abstract][Full Text] [Related]
33. Pharmaceutical Cocrystal: An Antique and Multifaceted Approach.
Panzade PS; Shendarkar GR
Curr Drug Deliv; 2017; 14(8):1097-1105. PubMed ID: 27758692
[TBL] [Abstract][Full Text] [Related]
34. Creation of Hydrochlorothiazide Pharmaceutical Cocrystals Via Hot-Melt Extrusion for Enhanced Solubility and Permeability.
Narala S; Nyavanandi D; Alzahrani A; Bandari S; Zhang F; Repka MA
AAPS PharmSciTech; 2022 Jan; 23(1):56. PubMed ID: 35043282
[TBL] [Abstract][Full Text] [Related]
35. Understanding the Effects of a Polymer on the Surface Dissolution of Pharmaceutical Cocrystals Using Combined Experimental and Molecular Dynamics Simulation Approaches.
Kirubakaran P; Wang K; Rosbottom I; Cross RBM; Li M
Mol Pharm; 2020 Feb; 17(2):517-529. PubMed ID: 31887053
[TBL] [Abstract][Full Text] [Related]
36. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
Li Z; Matzger AJ
Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376
[TBL] [Abstract][Full Text] [Related]
37. Isostructural cocrystals of metaxalone with improved dissolution characteristics.
Gohel SK; Palanisamy V; Sanphui P; Prakash M; Singh GP; Chernyshev V
RSC Adv; 2021 Sep; 11(49):30689-30700. PubMed ID: 35479860
[TBL] [Abstract][Full Text] [Related]
38. Superior Solubility and Dissolution of Zaltoprofen via Pharmaceutical Cocrystals.
Panzade P; Shendarkar G
Turk J Pharm Sci; 2019 Sep; 16(3):310-316. PubMed ID: 32454729
[TBL] [Abstract][Full Text] [Related]
39. Bioavailability of indomethacin-saccharin cocrystals.
Jung MS; Kim JS; Kim MS; Alhalaweh A; Cho W; Hwang SJ; Velaga SP
J Pharm Pharmacol; 2010 Nov; 62(11):1560-8. PubMed ID: 21039541
[TBL] [Abstract][Full Text] [Related]
40. Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds.
Shiraki K; Takata N; Takano R; Hayashi Y; Terada K
Pharm Res; 2008 Nov; 25(11):2581-92. PubMed ID: 18651208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
